Celldex
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Celldex and other ETFs, options, and stocks.About CLDX
Celldex Therapeutics, Inc. engages in the business of development, manufacturing and commercialization of novel therapeutics for human health care. Its drug candidates have the ability to engage the human immune system and directly inhibit tumors to treat specific types of cancer and other diseases.
CLDX Key Statistics
Stock Snapshot
As of today, Celldex(CLDX) shares are valued at $25.77. The company's market cap stands at 1.71B, with a P/E ratio of -7.89.
During the trading session on 2025-12-17, Celldex(CLDX) shares reached a daily high of $26.95 and a low of $25.70. At a current price of $25.77, the stock is +0.3% higher than the low and still -4.4% under the high.
Trading activity shows a volume of 675.7K, compared to an average daily volume of 895.02K.
Over the past 52 weeks, Celldex(CLDX) stock has traded between a high of $30.50 and a low of $14.40.
Over the past 52 weeks, Celldex(CLDX) stock has traded between a high of $30.50 and a low of $14.40.
CLDX News
Celldex Therapeutics (CLDX) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund l...
Celldex Therapeutics (CLDX) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund l...
Earlier this week, Celldex Therapeutics announced it has begun a global Phase 3 EMBARQ trial of barzolvolimab in adults with cold urticaria and symptomatic derm...
